Renin–angiotensin-system inhibitors and all-cause mortality in patients with coronavirus disease 2019

Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19

(2020) Reinhold Kreutz et al.   CARDIOVASCULAR RESEARCH

COVID-19 and Renin Angiotensin Blockers: Current Evidence and Recommendations

(2020) Franz H. Messerli et al.   CIRCULATION

Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19

(2020) Peng Zhang et al.   CIRCULATION RESEARCH

Clinical Impact of Renin-angiotensin System Inhibitors on In-hospital Mortality of Patients With Hypertension Hospitalized for Coronavirus Disease 2019

(2020) Sara Tedeschi et al.   CLINICAL INFECTIOUS DISEASES

Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study

(2020) Sun-Young Jung et al.   CLINICAL INFECTIOUS DISEASES

Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study

(2020) Bertrand Cariou et al.   DIABETOLOGIA

Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

(2020) Wei-jie Guan et al.   EUROPEAN RESPIRATORY JOURNAL

Influence of inhibitors of the renin–angiotensin system on risk of acute respiratory distress syndrome in Danish hospitalized COVID-19 patients

(2020) Anders Holt et al.   JOURNAL OF HYPERTENSION

Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study

(2020) Francisco J de Abajo et al.   LANCET

Association between Angiotensin Blockade and Incidence of Influenza in the United Kingdom

(2020) Sheng-Chia Chung et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19

(2020) John A. Jarcho et al.   NEW ENGLAND JOURNAL OF MEDICINE

Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19

(2020) Giuseppe Mancia et al.   NEW ENGLAND JOURNAL OF MEDICINE

Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19

(2020) Harmony R. Reynolds et al.   NEW ENGLAND JOURNAL OF MEDICINE

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19

(2020) Muthiah Vaduganathan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Drugs and the renin-angiotensin system in covid-19

(2020) Jeffrey K Aronson et al.   BMJ-British Medical Journal

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

(2020) Lei Fang et al.   Lancet Respiratory Medicine

Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020

(2020) Shikha Garg et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers

(2020) Chirag Bavishi et al.   JAMA Cardiology

Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)

(2020) Neil Mehta et al.   JAMA Cardiology

Association between angiotensin blockade and COVID-19 severity in Hong Kong

(2020) Ka Shing Cheung et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19

(2020) Xiao-Jing Zhang et al.   Cell Metabolism

Is the use of ACE inb/ARBs associated with higher in-hospital mortality in Covid-19 pneumonia patients?

(2020) Murat Selçuk et al.   CLINICAL AND EXPERIMENTAL HYPERTENSION

Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study

(2020) Chao Gao et al.   EUROPEAN HEART JOURNAL

Renin-Angiotensin System Blockers and the COVID-19 Pandemic

(2020) A.H. Jan Danser et al.   HYPERTENSION

Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality

(2020) Feng Zhou et al.   HYPERTENSION

Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality

(2020) Emil L. Fosbøl et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Baseline use of angiotensin-converting enzyme inhibitor/AT1 blocker and outcomes in hospitalized coronavirus disease 2019 African-American patients

(2020) Priyank Shah et al.   JOURNAL OF HYPERTENSION

Continued in-hospital ACE inhibitor and ARB Use in hypertensive COVID-19 patients is associated with positive clinical outcomes

(2020) Katherine W Lam et al.   JOURNAL OF INFECTIOUS DISEASES

Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID‐19 patients in Michigan, United States

(2020) Z. Imam et al.   JOURNAL OF INTERNAL MEDICINE

Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection

(2020) Anuradha Lala et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents

(2020) Anton De Spiegeleer et al.   Journal of the American Medical Directors Association

Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens

(2020) Francesca Bravi et al.   PLoS One

Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy

(2020) Giacomo Grasselli et al.   JAMA Internal Medicine

Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis

(2020) Jiuyang Xu et al.   Frontiers of Medicine

Association between renin–angiotensin system inhibitors and COVID-19 complications

(2020) Sophie Liabeuf et al.   European Heart Journal-Cardiovascular Pharmacotherapy

The association of hypertension and diabetes pharmacotherapy with COVID-19 severity and immune signatures: an observational study

(2020) Rinkoo Dalan et al.   European Heart Journal-Cardiovascular Pharmacotherapy

Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients

(2020) Gianluca Trifirò et al.   DRUG SAFETY

Association Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection in South Korea

(2020) Minkook Son et al.   HYPERTENSION

Renin–angiotensin system inhibitors and the severity of coronavirus disease 2019 in Kanagawa, Japan: a retrospective cohort study

(2020) Yasushi Matsuzawa et al.   HYPERTENSION RESEARCH

Association between renin–angiotensin–aldosterone system inhibitor treatment, neutrophil–lymphocyte ratio, D-Dimer and clinical severity of COVID-19 in hospitalized patients: a multicenter, observational study

(2020) Selcuk Gormez et al.   JOURNAL OF HUMAN HYPERTENSION

Outcomes of patients with end-stage kidney disease hospitalized with COVID-19

(2020) Jia H. Ng et al.   KIDNEY INTERNATIONAL

Random-Effects Meta-analysis of Inconsistent Effects: A Time for Change

(2014) John E. Cornell et al.   ANNALS OF INTERNAL MEDICINE

Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis

(2012) D. Caldeira et al.   BMJ-British Medical Journal